Neurologist and Duke ALS Clinic Director Richard Bedlack “stitches strength” for his patients, showing the powers of hope.

Inhibition of a cellular stress response may be a therapeutic target for ALS type 8 related to mutations in the VAPB gene, a ...

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose ...

TMTPOST -- Synchron Inc. has publicly demonstrated the world’s first successful control of Apple devices — including the iPad ...

The toxic cousin of gourmet fungi may harbor neurotoxins linked to ALS a fatal paralytic disorder, as suggested by a ...

Amylyx Pharmaceuticals, Inc. (($AMLX)) announced an update on their ongoing clinical study. Amylyx Pharmaceuticals, Inc. is conducting a Phase 1 ...

Eric Dane revealed he's been diagnosed with amyotrophic lateral sclerosis, also known as ALS. Here's what to know about the rare disease.

(Nasdaq: AMLX) ("Amylyx" or the "Company") today reported financial and business results for the second quarter ended June 30, 2025. "As we look ahead to the second half of the year and into 2026, we ...

Detailed price information for Eledon Pharmaceuticals Inc (ELDN-Q) from The Globe and Mail including charting and trades.

Hundreds of peer-reviewed studies on marijuana and its components have been published in the first seven months of 2025, ...